ARCHIVES

Phase IIb Trial of Vintafolide-Docetaxel Combination Meets Primary Endpoint of Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

Obesity At Prostate-Cancer Diagnosis Increases Risk

March 30, 2007

Terry To Leave As DRCCA Acting Director Sept. 1, Peter Greenwald Is DeVita’s Choice For The Job

August 14, 1981

Fitness Reduces Risk of Death From Lung, Colorectal, Prostate Cancer in Middle-Aged Men

May 31, 2013

NCI Advisory Group, Other Cancer Meetings

October 26, 1984

Screening Guidelines Differ Among Major Medical Organizations

January 16, 1998

Institute Of Medicine Report Says Insurers Should Pay Patient Care Costs In Clinical Trials

February 24, 1989